CMMB FY 2019 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena

CMMBChemomab Therapeutics Ltd.

$12M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$282,000

Operating Income

-$20M

Net Income

-$27M

EPS (Diluted)

$-63.20

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$20M

Total Liabilities

$5M

Stockholders' Equity

$12M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$282,000	-$65,785	-328.7%
Operating Income	-$20M	-$13M	-50.4%
Net Income	-$27M	-$14M	-97.2%